Orforglipron vs. semaglutide: Which one works best for weight loss?

The beginning of 2026 brought one of the biggest changes to the GLP-1 medication landscape as a new medication for weight loss was approved, called orforglipron. Named Foundayo®, it was added to already approved medications, semaglutide (Wegovy®) and tirzepatide (Zepbound®).

Orforglipron is a daily pill, like the newly approved Wegovy® pill, that came onto the market in late 2025. That brought two pills that were approved for weight loss, available to people managing obesity. Wegovy® is also still available as a once-weekly injection.

Both orforglipron and semaglutide are GLP-1 receptor agonists, which means they help reduce appetite, slow digestion, and regulate blood sugar, making them remarkably similar. But there are also important differences. How do you choose which is right for you? 

The answer isn’t always straightforward; it depends on your insurance, reaction to side effects, and how you want medication to fit into your day. Side effects and cost can vary between the two.

Orforglipron and semaglutide differ in how they’re taken and what clinical trials show about potential weight loss results. 

Let’s take a closer look at the biggest similarities and differences between orforglipron (Foundayo®) and semaglutide (Wegovy® injection and pill) to help you decide which option may best fit your goals and lifestyle.

Orforglipron vs. semaglutide: How do they work?

Both orforglipron and semaglutide mimic the GLP-1 hormone. GLP-1 is a hormone that gets released mainly after you eat, and it does a few helpful things: it helps regulate your appetite, slowing how quickly food leaves your stomach, and helps steady blood sugar. 

Semaglutide and orforglipron are designed to mimic that same system, which is why they’re classified as GLP-1 receptor agonists and why both can support meaningful weight loss over time.

As a pill: Both work in a similar way, mimicking the same hormone, but orforglipron is a different type of molecule than semaglutide. It’s a small-molecule drug rather than a peptide, which allows it to survive the digestive tract and be absorbed without the strict dosing requirements of semaglutide pills.

As an injection: Wegovy® also comes as a once-weekly injection, orforglipron isn’t available in injection form.

Learn more about orforglipron and semaglutide.

Orforglipron vs. semaglutide: What are the similarities?

Both orforglipron and semaglutide fall under the GLP-1 receptor agonist umbrella, meaning they share the same basic mechanism of action. That gives them a lot in common, and understanding those similarities is a helpful starting point before getting into where they differ.

• Both target the GLP-1 pathway. Even though they’re built differently, both medications activate GLP-1 receptors in your body. That can help you feel fuller after eating and less focused on food during the day.
• Both are made for long-term weight management. Weight loss builds over several months alongside healthy habits. 
• The dose will increase every 30 days (or longer) to lower the risk of side effects. You start at the lowest dose. 
• Both can cause similar digestive side effects. Since they work on the same hormone pathway, side effects like nausea, diarrhea, constipation, vomiting, and stomach discomfort are common to both. Side effects are most likely when first starting the medication and when the dose goes up.

Orforglipron vs. semaglutide: What are the differences?

Orforglipron and semaglutide have some things in common, but they also have differences that can have a big impact on your experience. From how they’re taken to how much weight people lost in studies, these details can help you figure out which option may feel like the better fit.

• Semaglutide is available in more forms. Orforglipron is currently available only as a daily pill under the brand name Foundayo^®. Semaglutide is available as the Wegovy^® tablet and injection for weight management.
• They come from different manufacturers. Orforglipron is made by Eli Lilly, while semaglutide is made by Novo Nordisk. 
• Orforglipron and semaglutide have different dosing schedules.
  • Orforglipron: Foundayo®is taken once daily, at any time, with or without food.
  • Semaglutide: The Wegovy^® tablet is taken on an empty stomach after waking with a small amount of water, and a 30-minute wait before eating or drinking anything else. Wegovy^® injections are taken once weekly with or without food. 
• Orforglipron is a non-peptide; semaglutide is a peptide. Semaglutide is structurally similar to GLP-1; both are peptides. It has a special absorption helper to make it work as a pill. The injectable form goes directly into the body. Orforglipron has a different molecular structure that makes it work as a pill taken any time of day.
• Semaglutide showed higher average weight loss in trials.
  • Across semaglutide’s forms, results ranged from an average weight loss of 14% to an average weight loss of about 18%, depending on the form. 
  • Orforglipron (Foundayo) showed an average weight loss of 11%. 
• Only semaglutide has additional approved indications beyond weight loss
  • Semaglutide also has approvals for cardiovascular risk reduction and treating MASH, a form of liver disease. It can also be prescribed for type 2 diabetes (as Ozempic).
  • Orforglipron (Foundayo) is currently approved for weight loss only.
• Storage requirements differ when using the injectable form. Oral forms of orforglipron and semaglutide can both be stored at room temperature. Semaglutide injection pens need to be refrigerated before use.

Orforglipron vs. semaglutide: Which is better for weight loss?

Both medications produce meaningful weight loss results, but semaglutide has been more effective in clinical trials in both pill and injection forms. Here’s what the research shows:

These results come from separate clinical trials with different study designs, so treat them as a general guide rather than a direct side-by-side comparison.

• Orforglipron: People taking the highest approved dose of Foundayo®(17.2 mg) saw an average weight loss of 11% over 72 weeks. 
• Semaglutide: The Wegovy® injection (7.2 mg) was associated with an average weight loss of about 18% over 72 weeks. The Wegovy® pill showed an average weight loss of 14% over 64 weeks. 

How much weight you lose with either medication depends on your individual response, starting weight, and the lifestyle habits you build alongside it.

How long does it take to see results?

Results build over time with both medications. Here’s what clinical trials showed at the highest approved doses for semaglutide and orforglipron:

After 3 months

• Semaglutide injection (7.2 mg): 6%
• Semaglutide pill (25 mg): 6%
• Orforglipron (17.2 mg): 7%

After 6 months

• Semaglutide injection (7.2 mg): 12%
• Semaglutide pill (25 mg): 11%
• Orforglipron (17.2 mg): 10%

After 1 year and beyond

• Semaglutide injection (7.2 mg): 18%
• Semaglutide pill (25 mg): 14%
• Orforglipron (17.2 mg): 11%

Everyone’s experience is a little different. Where you start, how consistently you take the medication, and the habits you build around it all shape what your results actually look like.

Who can take orforglipron or semaglutide for weight loss?

If you’re interested in orforglipron or semaglutide, eligibility usually comes down to a combination of your BMI and your overall health picture.

You may be eligible if you:

• Have a BMI of 30 or higher, or
• Have a BMI of 27 or higher and a weight-related health condition, like high blood pressure or high cholesterol

Whether you’re prescribed orforglipron or semaglutide, the medication is meant to work alongside long-term lifestyle changes. Things like nutrition, physical activity, sleep, and other daily habits still play an important role in helping you get the most from treatment. 

Who shouldn’t take orforglipron or semaglutide?

Your doctor will want to know your full health history before moving forward with either one.

You can’t take orforglipron and semaglutide if you:

• Have a personal or family history of medullary thyroid carcinoma (MTC) or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Have had a serious allergic reaction to either medication or its ingredients
• Are pregnant, planning a pregnancy, or breastfeeding

Your doctor will also want to know if any of the following apply to you:

• Past or current pancreatitis or kidney issues
• Gallbladder problems or a history of gallstones
• Gastroparesis

Planned surgeries or procedures are worth mentioning too, since both medications affect how quickly your stomach empties, and that can interact with anesthesia. The more your doctor knows upfront, the better they can guide you.

Orforglipron vs. semaglutide: How long do you need to take them?

Orforglipron and semaglutide are designed to support long-term weight management. While you’re taking them, they help regulate appetite, fullness, and other signals involved in eating. If the medication is stopped, those effects gradually fade, which is one reason healthcare providers often think about these treatments as part of a longer-term plan. 

If you’re thinking about stopping, here’s what to know: 

• Weight regain is possible. Many people regain at least some of the weight they lost after stopping a GLP-1 medication, although the amount can vary from person to person.
• The medication doesn’t change the way your body works. Orforglipron and semaglutide help create changes while you’re taking them. Once treatment ends, hunger and fullness signals may gradually shift back toward where they were before.
• Some people stay on treatment long-term. For many people, a maintenance dose — a lower or continued dose to help hold onto results — becomes part of their long-term plan. Research shows that weight regain is common after stopping GLP-1 medications, which is why continuing treatment at a maintenance level is often recommended for those who are tolerating it well and seeing benefits.
• You can always restart. If things start shifting after you stop, going back on medication or exploring a different option is something you can discuss with your doctor. 

Your provider can help you decide what makes sense for your situation and whether continuing, stopping, or adjusting treatment is the right next step.

Read more: Stopping Wegovy®: What to expect & how to manage weight after

Orforglipron vs. semaglutide: Dosage and administration

How you actually take these medications day to day is one of the more practical differences to consider. Orforglipron is designed to be simple: one pill taken once daily, with or without food. Semaglutide offers more flexibility in form, but each option comes with its own routine. The injectable version is taken once weekly, while the pill requires careful timing around meals and other medications. 

Here’s a look at the medications side by side:

Feature	Wegovy® Injection (semaglutide)	Wegovy® pill (semaglutide)	Foundayo® (orforglipron)
Form	Prefilled injection pen	Tablet	Tablet
How often	Once weekly	Once daily	Once daily
How it’s taken	Injected under the skin of the abdomen, thigh, or upper arm	Taken by mouth	Taken by mouth
Food requirements	None	Must be taken on a completely empty stomach	Can be taken with or without food
Timing requirements	Same day each week	First thing in the morning	Any time of day
Water restrictions	None	Use no more than 4 ounces of water	None
After taking	No waiting period	Wait at least 30 minutes before eating, drinking, or taking other medications	No waiting period
Storage	Refrigeration required before use	Room temperature	Room temperature
Self-administration	Yes	Yes	Yes

Orforglipron vs. semaglutide: How are the doses increased?

Both orforglipron and semaglutide use a gradual titration approach. You start at the lowest dose and increase slowly over several months. This is designed to reduce the risk of side effects like nausea and vomiting, which tend to be most pronounced when starting the medication or moving up to a higher dose.

Foundayo® (orforglipron)

For Foundayo, you’ll start at the lowest dose, and it will be increased every 30 days or longer, depending on your results and side effects. Here’s how the general schedule works:

• Days 1–30: 0.8 mg once daily
• Days 31–60: 2.5 mg once daily
• Days 61–90: 5.5 mg once daily
• Day 91 onward: Your provider may continue increasing the dose (9 mg, 14.5 mg, 17.2 mg) in 30-day intervals based on your response and tolerability
• Maximum dose: 17.2 mg once daily

Not everyone needs to reach the highest dose. Your provider will determine the right maintenance level for you.

Wegovy® injection (semaglutide)

The injection increases every four weeks as tolerated:

• Weeks 1–4: 0.25 mg
• Weeks 5–8: 0.5 mg
• Weeks 9–12: 1.0 mg
• Weeks 13–16: 1.7 mg
• Weeks 17–20: 2.4 mg
• Week 21 onward: 7.2 mg (for people who tolerate 2.4 mg and need additional weight loss)

Wegovy® pill (semaglutide)

The tablet starts at 1.5 mg once daily and increases every 30 days, as needed and tolerated:

• Days 1–30: 1.5 mg once daily
• Days 31–60: 4 mg once daily
• Days 61–90: 9 mg once daily
• Day 91 onward: 25 mg once daily (target maintenance dose)

Can titration be slowed down?

Yes, for all three forms:

• For Wegovy®, if a dose isn’t tolerated during escalation, your provider can delay the next increase by four weeks
• For Foundayo®, the prescribing information instructs providers to consider tolerability at each dose level before moving up

The goal is to find the highest dose you can sustain comfortably, not to hit a number on a schedule.

Can titration be sped up?

No, not beyond what the approved label allows:

• The Foundayo® and Wegovy® pill prescribing information specifies a minimum of 30 days at each dose level
• The Wegovy® prescribing information requires a minimum of four weeks between increases

Moving up too quickly increases GI side effects without improving weight loss outcomes. Any schedule adjustments should come from your provider based on your individual response.

Read more:

• Foundayo^® dosage: Getting the dose right for weight loss
• Semaglutide: Finding the right dose for weight loss

Orforglipron vs. semaglutide: Costs and insurance considerations

Cost can be one of the biggest deciding factors when people are choosing a weight loss medication. The important thing to know is that there isn’t one price that applies to everyone. What you pay can depend on the medication, your insurance coverage, available savings programs, and where you get your prescription filled. Here’s what the costs look like across both medications:

Let’s take a look at orforglipron and semaglutide.

Orforglipron (Foundayo®)

Foundayo^® is available through insurance and via the LillyDirect cash-pay programs, with pricing based on your prescribed dose.

Brand name	Cost (monthly)
Foundayo®	List price: With insurance: Some people with commercial insurance may pay as little as $25/month with savings programs. Learn more. Paying cash:  LillyDirect® program pricing $149: 0.8 mg $199: 2.5 mg $299: 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg Learn more about the cost of Foundayo®.

Semaglutide

Wegovy^® costs can vary based on insurance coverage and dose if paying cash.

Brand name	Cost (monthly)
Wegovy® injection	List price: $1,349 With insurance: Some people with commercial insurance may pay as little as $25/month with savings programs. Learn more. Cash pay: NovoCare® Pharmacy pricing $199–$349: 0.25 mg and 0.5 mg $349: 1 mg, 1.7 mg, and 2.4 mg $399: 7.2 mg Learn more about the cost of Wegovy®.
Wegovy® pill	List price: $1,349 With insurance: Some people with commercial insurance may pay as little as $25/month with savings programs. Learn more. Cash pay: NovoCare® Pharmacy pricing $149: 1.5 mg  $149–$199: 4 mg  $299: 9 mg and 25 mg Learn more about the cost of Wegovy® pills.

When does insurance cover orforglipron or semaglutide for weight loss? 

Insurance coverage for weight loss medications is still largely unlikely, but you should always check your plan’s approved medications, as rules change all the time. Two people with the same prescription can end up paying very different amounts depending on their insurance plan, employer benefits, and the reason the medication was prescribed.

Here’s what you can generally expect:

• Orforglipron (Foundayo^®)
  • Private insurance: May be covered if your plan includes weight loss coverage. 
  • Medicare: Medicare doesn’t cover medications prescribed solely for weight loss, but beginning July 1, 2026, eligible Medicare Part D beneficiaries can access Foundayo® for a $50 monthly copay through the program. Learn more.
  • Medicaid: Coverage varies by state. 

Learn more: Foundayo® cost: With and without insurance in 2026

• Wegovy^®
  • Private insurance: Wegovy® is covered by some plans. Check your plan-specific eligibility with Noom’s Insurance Checker. 
  • Medicare: Medicare doesn’t cover medications prescribed solely for weight loss, but beginning July 1, 2026, eligible Medicare Part D beneficiaries can get Wegovy® (pill and injection) through the Medicare GLP-1 Bridge program. 
  • Medicaid: Coverage varies by state. 
• Many plans require prior authorization. That means your healthcare provider may need to submit paperwork showing that you meet the plan’s requirements.
• Some plans don’t cover weight loss medications at all. In those cases, cash-pay programs or manufacturer savings offers may become important options.

Read more: What does Wegovy® cost without insurance? How to navigate pricing in 2026

Orforglipron vs. semaglutide: Side effects and safety

For both orforglipron and semaglutide, side effects are most likely to show up when you’re first starting the medication or moving up to a higher dose. Many people find that symptoms become easier to manage with time.

Here’s a look at some of the most commonly reported side effects at the highest approved dose of each medication. All results come from separate studies, so it’s best to treat these numbers as a general guide rather than a direct apples-to-apples comparison across all products.

Side effect	Wegovy® HD (7.2 mg)	Wegovy® pill (25 mg)	Foundayo® (17.2 mg)
Nausea	39%	47%	35%
Vomiting	22%	31%	24%
Diarrhea	NR	18%	25%
Constipation	20%	20%	24%
Dyspepsia	NR	18%	13%
Abdominal pain	12%	7%	14%
Headache	9%	12%	9%
Fatigue	11%	7%	9%

*NR = not reported in prescribing information at the threshold used for this table, not that the side effect was absent. Diarrhea and dyspepsia have been reported with injectable semaglutide in clinical trials.

Looking across the table, nausea is common across all four medications, but stands out as highest with the oral options—particularly oral semaglutide (Wegovy® pill)  at 47%. 

• Vomiting follows a similar pattern, with oral semaglutide (31%) and orforglipron (24%) both running higher than the injectable semaglutide. It’s worth noting that orforglipron’s vomiting rate is closer to oral semaglutide than to the injectables, a reminder that switching from an injectable to a pill doesn’t necessarily mean fewer GI side effects.
• Constipation is notably consistent across all four medications (19–24%), suggesting this may be a class effect of GLP-1 receptor agonists rather than something specific to any one formulation or route.

Beyond these shared side effects, injectable semaglutide can also cause injection-site reactions, like redness, itching, or irritation—something you won’t get with oral options like orforglipron or oral semaglutide.

Keep in mind that since these numbers don’t all come from the same study, they’re best used to spot general patterns, not to predict exactly how your body will respond to each medication.

Read more: 

• Foundayo^® side effects
• Semaglutide side effects

Serious side effects and warnings

Serious side effects with orforglipron and semaglutide are uncommon, but they’re still important to know about. Knowing the symptoms to look out for can help you act quickly if they happen. Overall, they are similar and include: 

• Pancreatitis (inflammation of the pancreas): Watch for severe pain in the upper stomach that won’t go away and may spread to your back, sometimes accompanied by nausea or vomiting. Contact a healthcare provider right away.
• Vision changes: Blurry vision, trouble focusing, or sudden changes in your eyesight should be evaluated immediately, especially if you have diabetes.
• Low blood sugar (hypoglycemia): This is more likely if you’re also taking insulin or certain diabetes medications. Symptoms can include shakiness, sweating, dizziness, confusion, or a racing heartbeat. Seek medical care if symptoms are severe or don’t improve.
• Kidney problems: Severe nausea, vomiting, or diarrhea can sometimes lead to dehydration, which may affect kidney function. Contact your provider if you’re urinating much less than usual, notice swelling in your legs or feet, or feel unusually weak.
• Gallbladder problems: Pain in the upper right side of your abdomen, especially if it comes with fever, nausea, or yellowing of the skin or eyes, should be evaluated immediately.
• Serious allergic reactions: Swelling of the face, lips, tongue, or throat, trouble breathing, or severe rash require emergency medical attention.
• Boxed warning: Both orforglipron and semaglutide carry an FDA boxed warning about thyroid C-cell tumors. This risk was seen in animals, but it hasn’t been confirmed in humans. 

If something feels unusual or concerning, don’t wait for it to get worse. A quick call to your provider can often help you figure out the next step.

Read more: GLP-1 side effects: What to expect & how to manage them

Orforglipron vs. semaglutide: Which is safer? 

Neither orforglipron nor semaglutide is automatically safer than the other. Because both medications work through the GLP-1 pathway, they share many of the same side effects, warnings, and precautions. The better choice usually comes down to factors like your medical history, how well you tolerate side effects, your preference for a pill versus an injection, and how your body responds to treatment. Your provider can help determine which option makes the most sense for you.

Can you switch between orforglipron and semaglutide?

Yes, switching between orforglipron and semaglutide is possible, but it’s something you’ll want to do with guidance from your healthcare provider. Even though both medications work through the GLP-1 pathway, they’re different drugs with different dosing schedules and treatment routines.

• Why do people switch? Sometimes the decision comes down to cost, insurance coverage, or availability. Other times, it’s about convenience. You may prefer the flexibility of a daily pill like orforglipron, or you may like the simplicity of a weekly semaglutide injection. Side effects, weight loss progress, and personal preferences can also influence the decision.
• What might feel different after switching? The biggest change may be your routine. If you’re moving from a weekly semaglutide injection to daily orforglipron, you’ll go from thinking about your medication once a week to taking it every day. If you’re switching from oral semaglutide, you may appreciate that orforglipron doesn’t have the same timing and fasting requirements. Some people also notice differences in side effects or appetite changes when they switch medications.
• How does the switch usually happen? Your provider will help you figure out the right timing, including when to stop one medication and when to begin the next. They may also have you start at a lower dose and slowly work your way up, which gives your body more time to adjust.

Before making any changes, it’s always worth having a conversation with your provider to make sure the transition is safe and appropriate for your situation.

Orforglipron vs. semaglutide: Which is right for me? 

Choosing between orforglipron and semaglutide often comes down to balancing convenience, cost, weight loss expectations, and your personal preferences. Some people love the flexibility of a pill they can take every day, while others would rather think about their medication just once a week. Looking at the key differences side by side can help make the decision feel a little clearer. 

Medication	Orforglipron	Semaglutide
Brand names	Foundayo®	Wegovy®
Manufacturer	Eli Lilly	Novo Nordisk
Dosing formats	Daily pill	Weekly injection and daily pill
Available doses	0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg	Injection: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, 7.2 mg Pill: 1.5 mg, 4 mg, 9 mg, 25 mg
Pricing per month (without insurance)	Around $649 list price	Wegovy® (injection and pill): $1,349
Cash-pay programs	Through LillyDirect® $149: 0.8 mg $199: 2.5 mg $299: 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg	Through NovoCare® Pharmacy Injection:  $199–$349: 0.25 mg and 0.5 mg $349: 1 mg, 1.7 mg, and 2.4 mg $399: 7.2 mg Pill: $149: 1.5 mg  $149–$199: 4 mg  $299: 9 mg and 25 mg
Dosing instructions	Can be taken with or without food at any time of day	Weekly injection: Take it once weekly. You choose a consistent day of the week and can take it with or without food Daily pill: Take in the morning on an empty stomach with a little water; wait 30 minutes before eating or drinking
Average weight loss	11% of starting body weight over 72 weeks.	Weekly injection: 18% of starting body weight over 72 weeks.  Daily pill: 14% of starting body weight over 64 weeks.
Side effects	Similar side effects, but diarrhea, abdominal pain, and constipation tend to be reported at higher rates with orforglipron than with semaglutide.	Similar side effects, but injectable semaglutide may also cause injection-site reactions like redness, itching, or irritation.

The bottom line: Choosing between orforglipron and semaglutide forms depends on your biology and goals

Both orforglipron and semaglutide can help you lose meaningful weight, but they’re not identical medications. Semaglutide brings a longer clinical history, more available formats, and higher average weight loss results across its injectable and oral forms. Orforglipron is newer, available only as a daily pill, and comes with fewer dosing restrictions, which can be a real advantage depending on your lifestyle.

Side effects, safety warnings, insurance coverage, and cost all matter too. These medications are meant for long-term support, so it’s worth thinking about what you can realistically stick with, not just what looks best on paper. 

If you’re curious about which option may make sense for you, see if you qualify for Noom Med. If you do, a clinician can review your health history, talk through medication options, and help you build a plan that supports your goals beyond the prescription.

Note: Ozempic^® is not FDA-approved to treat obesity or for weight loss.